HopeStage
Back to all studies
CompletedNCT06500624

Escitalopram alone or with pizotifen for depression

About this titleRead the official source — NCT06500624
Medication studyAges 18–70Pakistan
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 70 years.

Listed locations
RawalpindiSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: June 3, 2024
Recruitment status
Completed
Enrollment listed in the registry
88
Sponsor
Riphah International University
Sponsor type
University
Study type
Drug
Intervention type
Drug
Locations
Pakistan
Age range
From 18 Years to 70 Years
Official registry ID
NCT06500624
Official title
Show the full official title

Comparative Efficacy of Escitalopram Monotherapy and Escitalopram in Adjuvant With Pizotifen in Depressive Disorder

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Rawalpindi

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Riphah International University, a university.

Did this study involve medication?

Yes. The study involved medication, including Pizotifen.

Who was this study for?

Listed age limits: 18 years to 70 years.

Want to explore more studies?

Explore studies